Pathophysiology of ketoacidosis in Type 2 diabetes mellitus
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aims Despite an increasing number of reports of ketoacidosis in populations with Type 2 diabetes mellitus, the pathophysiology of the ketoacidosis in these patients is unclear. We therefore tested the roles of three possible mechanisms: elevated stress hormones, increased free fatty acids (FFA), and suppressed insulin secretion. Methods Forty‐six patients who presented to the Emergency Department with decompensated diabetes (serum glucose > 22.2 mmol/l and/or ketoacid concentrations ≥ 5 mmol/l), had blood sampled prior to insulin therapy. Three groups of subjects were studied: ketosis‐prone Type 2 diabetes (KPDM2, n = 13) with ketoacidosis, non‐ketosis‐prone subjects with Type 2 diabetes (DM2, n = 15), and ketotic Type 1 diabetes (n = 18). Results All three groups had similar mean plasma glucose concentrations. The degree of ketoacidosis (plasma ketoacids, bicarbonate and anion gap) in Type 1 and 2 subjects was similar. Mean levels of counterregulatory hormones (glucagon, growth hormone, cortisol, epinephrine, norepinephrine), and FFA were not significantly different in DM2 and KPDM2 patients. In contrast, plasma C‐peptide concentrations were approximately three‐fold lower in KPDM2 vs. non‐ketotic DM2 subjects (P = 0.0001). Type 1 ketotic subjects had significantly higher growth hormone (P = 0.024) and FFA (P < 0.002) and lower glucagon levels (P < 0.02) than DM2. Conclusions At the time of hospital presentation, the predominant mechanism for ketosis in KPDM2 is likely to be greater insulinopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460
Glucagon physiology and pathophysiology in the light of new advances
Unger, R. H. (1985) · Diabetologia · doi:10.1007/bf00281991 · Cited by 361
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Cited by
Diabetes classification: grey zones, sound and smoke: Action LADA 1
Leslie, R. D. G., Kolb, H., Schloot, N. C., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Sarti, C., Thivolet, C., Hadden, D., et al. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.877 · Cited by 136
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
Simes, B. C., & MacGregor, G. G. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s212003 · Cited by 103
GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences
Forouzanmehr, B., Hemmati, M. A., Atkin, S. L., Jamialahmadi, T., Yaribeygi, H., & Sahebkar, A. (2025) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-024-03384-1 · Cited by 3
“Acetone is produced through the process of spontaneous decarboxylation of acetoacetate (Ghimire et al. 2023; Linfoot et al. 2005; Dhillon and Gupta 2023; Trugo and Finglas 2003; Caballero et al. 2003).”
Metadata
- Authors
- Linfoot, P., Bergstrom, C., & Ipp, E.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2005-09-13
- Volume
- 22
- Issue
- 10
- Pages
- 1414-1419
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2001790198
- Cited by
- 39
- References
- 3
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiology of ketoacidosis in Type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1111/j.1464-5491.2005.01660.x
- The paper
- Linfoot, P., Bergstrom, C., & Ipp, E. (2005). Pathophysiology of ketoacidosis in Type 2 diabetes mellitus. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2005.01660.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.